The post, which includes a chart detailing these and other alleged statistics, claims the vaccine "may not be effective" in people 60 and older with severe risk factors for COVID-19. PIC general ...

and Johnson & Johnson vaccines are all highly effective in protecting you from the virus that causes COVID-19. The CDC says there’s a preference for the mRNA (Pfizer and Moderna) COVID-19 ...

A study published in the CDC’s online journal Morbidity and Mortality Weekly Report showed that the updated vaccine was essentially equally effective at protecting against the strain targeted by ...

Current vaccines were designed to work against the SARS-CoV-2 coronavirus that originated in Wuhan, China. But as the virus evolves around the world, new variants are emerging that seem to evade ...

A new type of mRNA vaccine is more scalable and adaptable to continuously evolving viruses such as SARS-CoV-2 and H5N1, ...

The study didn't examine the updated bivalent boosters. COVID-19 vaccine effectiveness against omicron infection fell dramatically after six months for people who only got their primary series ...

Vaccine effectiveness was initially termed “field efficacy”. Essentially, vaccine effectiveness is a “real world” view of how a vaccine reduces disease in a population. This vaccine may ...

The two sets of chart reviews — one ... which may be effective against nonbacteremic pneumococcal pneumonia, 14 and protein vaccines, such as pneumococcal surface protein A formulations, 37,38 ...